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Targeting Bacterial Virulence:
Inhibitors of Type III Secretion in Yersinia
tial for the bacteria to evade the immune defense, and
it is likely that agents that inhibit secretion can result
in an antibacterial response without actually killing the
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1Organic Chemistry bacteria. This chemical attenuation will enable the host
to clear the infection, and we hypothesize that the selec-Department of Chemistry
2 Department of Molecular Biology tive pressure for resistance will be dramatically less than
for conventional antibiotics since the cost of mutatingUmea˚ University
SE-90187 Umea˚ a specific virulence attribute is probably very high. Com-
pounds that target TTS can also be employed as chemi-Sweden
cal probes to further study the secretion and its regula-
tion using chemical genetics [7, 8]. The approach of
using small molecules to study cellular microbiologySummary
holds great promise, but only a few examples can be
found in the literature [9]. Moreover, several mammalianAgents that target bacterial virulence without detri-
mental effect on bacterial growth are useful chemical pathogens, including Yersinia species, Salmonella spe-
cies, Shigella flexneri, Pseudomonas aeruginosa, en-probes for studies of virulence and potential candi-
dates for drug development. Several gram-negative teropathogenic Escherichia coli, Chlamydia species,
and also plant pathogens like Xanthomonas campestris,pathogens employ type III secretion to evade the in-
nate immune response of the host. Screening of a Erwinia species, Pseudomonas syringae, and Ralstonia
solanacearum, employ closely related TTS systems thatchemical library with a luciferase reporter gene assay
in viable Yersinia pseudotuberculosis furnished sev- are crucial for virulence [10, 11]. The most ancient TTS
system is the machinery involved in assembly of flagellaeral compounds that inhibit the reporter gene signal
expressed from the yopE promoter and effector pro- [10]. It was recently reported that the flagellar type III
export apparatus in Y. enterocolitica also functions astein secretion at concentrations with no or modest
effect on bacterial growth. The selectivity patterns ob- a protein secretion system [12]. This important observa-
tion was corroborated by the finding that the YplA pro-served for inhibition of various reporter gene strains
indicate that the compounds target the type III secre- tein of Y. enterocolitica in fact is secreted by the Ysc,
the chromosomally encoded Ysa (Yersinia secretiontion machinery at different levels. Identification of this
set of inhibitors illustrates the approach of utilizing apparatus), and the flagellar TTS systems in Y. entero-
colitica [13]. Interestingly, some components of TTScell-based assays to identify compounds that affect
complex bacterial virulence systems. systems in different species are interchangeable, sug-
gesting evolutionary conservation and that data gener-
ated with one specific TTS system might be valid alsoIntroduction
for others [14]. The relevance of Yersinia TTS-based
research is further underscored by the fact that multire-Recent studies have revealed that various pathogenic
bacteria use related virulence systems, findings that sistance strains have been found in Y. pestis [15, 16],
and that Y. pestis is a potential weapon in biologicalcontradict the long-held paradigm that each bacterium
has a unique mode of action. These findings have impli- warfare and bioterrorism [17, 18].
The components of the plasmid-encoded Ysc type IIIcations for development of novel antibacterial agents
as well as research aimed at understanding bacterial virulence system, i.e., the effector proteins (Yops) and
proteins involved in regulation and secretion, are en-virulence. The plasmid-encoded Ysc (Yersinia secretion)
type III secretion (TTS) system of Yersinia represents the coded by a 70 kb virulence plasmid [19]. Although
many functions of the Yersinia TTS and its regulationarchetype of one of these common virulence systems in
which the bacterium adheres to a eukaryotic cell and are poorly understood, results from different labora-
tories have contributed to provide a broad picture ofinjects a set of bacterial effector proteins, Yops (Yersinia
secretion-related events [2, 10, 11]. When the bacteriumouter proteins), into the lumen of the target cell, resulting
enters the host, the temperature shift to 37C inducesin inhibition of the innate immune response [1, 2]. The
a pathogenic switch in which20 Ysc proteins that formgenus Yersinia includes eleven known species, of which
the secretion apparatus spanning the bacterial inner andY. pestis, Y. pseudotuberculosis, and Y. enterocolitica
outer membranes are produced. This temperature shiftare pathogenic to humans. Y. pestis, the causative agent
also results in expression of chaperones, Sycs (specificof plague, is one of the most virulent bacteria known
yop chaperones). Expression of the Ysc proteins, Sycsto man [3]. Bacterial virulence systems, such as the
and Yops, is regulated by the temperature-induced acti-processes of protein secretion across the bacterial
vator protein LcrF [20]. The negative element, LcrQ, onmembranes and translocation into the target cell, repre-
the other hand, suppresses full expression of the Yopssent attractive points of attack for development of novel
until the bacterium is directly in contact with a eukaryoticantibacterial agents [4–6]. The TTS apparatus is essen-
cell [21]. Upon this intimate contact with the eukaryotic
target cell, LcrQ is secreted, resulting in elevated Yop*Correspondence: mikael.elofsson@chem.umu.se
3 These authors have contributed equally to this work. production [21]. The cognate Sycs then bind to the newly
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produced Yops and deliver them to the Ysc apparatus.
In parallel, a poorly understood chain of events results
in formation of a pore in the eukaryotic cell membrane.
The Yops are secreted through the Ysc machinery and
then likely translocated through the pore into the cyto-
plasm of the eukaryotic cell [2]. In the eukaryotic cell,
six different Yops, YopE, YopH, YpkA, YopJ, YopM, and
YopT, specifically inactivate innate immune reactions [1].
To enable identification of novel antibacterial agents
and chemical probes for chemical genetics, we devel-
oped a whole-cell bacterial reporter gene assay based
on Y. pseudotuberculosis. This assay can be used to
identify compounds that target known or unknown com-
ponents directly or indirectly affecting the Ysc TTS ma-
chinery. The assay relies on monitoring expression from
the yopE promoter. It has been employed to screen a
9,400 compound library, yielding several molecules
that inhibit TTS at concentrations that do not prevent
bacterial growth.
Results and Discussion
In Vitro Regulation of Secretion and Reporter
Gene Constructs
With the aim to develop an assay that can detect com-
pounds that affect both known and unknown targets
involved in the Ysc TTS system, we focused on a tran-
scriptional reporter gene assay in viable bacteria. Regu-
lation of this TTS machinery in Y. pseudotuberculosis is
relatively well understood, and its comparatively low
virulence in humans made it a suitable candidate for
assay development. Interestingly, the expression and
secretion of Yops has been found to be Ca2 dependent
Figure 1. The Current Model for Regulation of Yop and Syc Expres-in vitro. At 26C, Yersinia grow both in the presence and
sion Involving Temperature and Ca2 Dependence via the Positive
absence of Ca2, whereas millimolar concentration of Element LcrF and the Negative Element LcrQ in Wild-Type Y. pseu-
Ca2 is required for growth at 37C. In Ca2-depleted dotuberculosis Harboring the Virulence Plasmid pIB102
medium at 37C, a metabolic downshift is observed and (A) At 37C, LcrF is a positive regulator of Syc and Yop expression,
growth is halted after a few generations [22]. This is but at this stage Yop expression is suppressed by the negative
regulator LcrQ.accompanied by LcrQ secretion and subsequent strong
(B) Upon eukaryotic cell contact or Ca2 depletion at 37C, LcrQ isexpression and secretion of the Yops in absence of
secreted, resulting in Yop expression.eukaryotic cells [23]. The role of this Ca2 dependence
(C) Schematic representation of reporter gene constructs for identifi-
in vivo has, however, not been clarified. The simplified cation of inhibitors or activators of Yersinia TTS in the absence of
regulatory model for Syc and Yop expression given in eukaryotic target cells.
Figures 1A and 1B was used to design reporter gene
constructs for screening in the absence of eukaryotic
target cells. For a transcriptional reporter system, we resulting strains pIB102EL [25] and pIB29EL were found
to exhibit secretion properties, including in vitro temper-employed the luciferase gene from Vibrio Harveyi [24]. In
the presence of n-decanal, this enzyme oxidates flavine ature and Ca2 regulation, identical to wild-type Y. pseu-
dotuberculosis (data not shown). Thus, using a bacte-mononucleotide, resulting in light emission at 490 nm.
The light signal can be detected with a light-sensitive rium with the luxAB reporter gene construct under the
control of a native virulence gene promoter, it is possiblecharge-coupled device (CCD) camera, thus enabling ef-
ficient monitoring of protein expression. Following a pre- to monitor processes regulating secretion-specific tran-
scription. In addition, it is possible to screen for inhibi-viously reported strategy, the luciferase-encoding hy-
brid gene, luxAB, was cloned to be under the control tors or activators in the absence of eukaryotic cells by
manipulating the temperature and the Ca2 concentra-of the effector protein yopE promoter on the virulence
plasmid in Y. pseudotuberculosis serotype III (YPIII) [25]. tion as schematically shown in Figure 1C. This cloning
strategy was also used to prepare an additional strainAll strains employed in this study are based on YPIII,
and in the following paragraphs the strains are labeled in which luxAB was cloned downstream of the promoter
for YerA, the specific YopE chaperone. In the resultingonly with the name of the virulence plasmid. The con-
struct was introduced in both wild-type bacteria wild-type (pIB102AL) strain, the luciferase expression is
dependent on temperature but independent of the Ca2(pIB102) [26] and a nonvirulent strain (pIB29) [27] which
lacks the gene for the effector protein YopH [27]. The concentration [28]. Notably, the luxAB reporter gene was
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Figure 2. Inhibition of the Reporter Gene Signal by a Monoclonal
Anti-YopB Antibody
Inhibition of the luciferase reporter gene light signal in the strain
pIB29EL by a mouse monoclonal anti-YopB antibody added at the
indicated time-points (t in minutes) during the assay process; n  4.
transcriptionally fused downstream of the structural
gene, generating a new operon structure. Thus, all
strains employed in this study exhibit wild-type pheno-
type with respect to regulation and virulence.
Assay Optimization: Scope and Limitations
A typical procedure involved diluting an overnight bacte-
Figure 3. Screening and Identification of Potential Type III Secretion
rial culture and dispensing it into 96-well plates. After Inhibitors
an initial incubation at room temperature that allows the (A) Screening for inhibitors of TTS. The photo shows a typical result
culture to attain stable growth, the plate is shifted to from the library screening campaign. One compound per well is
37C. In the absence of Ca2, growth is suppressed and screened at 20 g/ml in columns 2–11. The dark well in the lower left
corner contains 10 M streptomycin as positive control. RemainingYop secretion is activated. In the presence of Ca2, Yop
wells in columns 1 and 12 are used as controls. The white squaressecretion remains low and the bacteria continue to grow.
indicate potential screening hits.The plate is then shifted back to room temperature,
(B) Structures of the identified inhibitors 1–4.
and, finally, n-decanal is added and light emission is
measured. The assay conditions, including initial bacte-
rial density, incubation times, etc., have been optimized the secretion system is activated, but increased Yop
(data not shown) to give a robust and reliable system expression is not detectable until after approximately 1
primarily for identification of Yop secretion inhibitors hr, indicating that addition of the Yop-neutralizing anti-
(see Experimental Procedures). body results in an immediate inhibitory response. Thus,
Since the assay is based on a transcriptional readout, agents that specifically target one component of the
compounds perturbing processes unrelated to TTS sys- TTS machinery can result in a complete suppression of
tems have the potential to result in reduction of light Yop expression.
emission. To address this issue, a number of well-stud- In conclusion, the assay can be used to screen for
ied antibiotics with known modes of actions were evalu- agents targeting different bacterial functions, including
ated. Carbenicillin, streptomycin, nalidixic acid, and compounds that specifically interfere with the Ysc TTS
polymyxin B all resulted in a dose-dependent inhibition system. Since the screening is performed with viable
of light emission with IC50 values of 15, 4, 15, and 0.15 bacteria, issues such as membrane permeability will be
M, respectively. These data clearly illustrate that the addressed directly. Moreover, the assay is well suited
assay, despite having only a short growth period (3 for high-throughput screening of large compound col-
hr), can efficiently detect bacteriocidal agents acting on lections.
a variety of bacterial targets.
The primary goal of this investigation was, however,
to use this assay to screen for novel agents specifically Screening for Secretion Inhibitors
The assay was used to screen a compound collectiontargeting the Ysc TTS system. We therefore evaluated
a panel of antibodies targeting a set of relevant Yersinia consisting of 9,400 unique substances (ChemBridge,
DiverSet F) for inhibition of the luxAB reporter signalproteins that putatively are present on the bacterial sur-
face and directly or indirectly regulate the secretion. using the nonvirulent strain pIB29EL (Figure 3A). The
compounds were screened in duplicates at a final con-Interestingly, a monoclonal antibody against YopB, one
of the putative pore-forming proteins [2], could com- centration of 20 g/ml. The complete screening cam-
paign gave 30 compounds that caused at least 40%pletely inhibit or reduce light emission when added to
the assay solution at time points up to 2 hr after start inhibition (duplicate average) of the luciferase light sig-
nal. For 26 of these compounds, dose-response rela-of the experiment (Figure 2). After the shift to 37C,
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Figure 5. Characterization of Screening Hits Using Strains with the
Reporter Gene Downstream of Different Virulence Promoters
Effect on luciferase light emission in different wild-type bacteria
(p102EL, black bars; pIB102AL, white bars; pIB102FL, gray bars) in
the presence of different concentrations of compounds 2–4; n  4.
Figure 4. Initial Hit Characterization cating that these substances possibly act on targets
Effect on luciferase light emission (black bars) and bacterial growth directly or indirectly regulating expression of the Yops
(white bars) for the nonvirulent screening strain pIB29EL in the pres- but not affecting growth (Figures 4B–4D).
ence of different concentrations of compounds 1–4; n  4.
Further Characterization of Screening Hits
A more detailed investigation was carried out for manytionships were established and inhibition of bacterial
growth was examined. All experiments based on the of the 26 compounds, although emphasis was placed
on compounds 2–4. As a first step, the compounds wereluciferase readout were carried out in quadruplicate in
the same manner as the primary screen (see Experimen- assayed using the wild-type control strain, pIB102AL,
with luxAB downstream of the promoter for YerA, thetal Procedures). Of the 26 compounds, 12 were found
to have an IC50 for inhibition of the luciferase light signal chaperone for YopE. As seen in Figures 5A and 5C,
compounds 2 and 4 showed a somewhat stronger inhibi-of 50 M or less (data not shown). In terms of growth
inhibition, the compounds could be divided into two tory effect on the wild-type strain pIB102EL with luxAB
under control of the yopE promoter than on pIB102AL.groups. In the first group, data for inhibition of growth
paralleled inhibition of light emission as shown for com- Compound 3, on the other hand, had no selectivity for
either of these two strains, as illustrated in Figure 5B.pound 1 (Figures 3B and 4A). Compounds 2–4 (Figure
3B) are representative of the second group in which no In order to zoom in on potential targets and to further
support a selective mode of action for compounds 2–4,or modest inhibition of growth was observed at concen-
trations that caused major reduction of the luciferase one additional wild-type strain with the luxAB gene
downstream from the lcrF promoter (pIB102FL) waslight signal (Figures 4B–4D). The inhibition of light emis-
sion observed for substance 1 is most likely a result of used. Based on the regulatory model in Figures 1A and
1B, compounds that inhibit the signal from both thethe growth inhibition rather than a direct interference
with the Ysc TTS system. Although not of primary inter- yopE and the yerA promoters could in fact target gene
expression of the positive regulator LcrF, since the yopEest for this investigation, such compounds are still valu-
able. To our knowledge, data regarding antibacterial and yerA promoters are both positively regulated by
LcrF. Importantly, in contrast to the yopE promoter, theeffect of 1 cannot be found in the literature. Compounds
2–4, on the other hand, show a selectivity for inhibition yerA promoter is not regulated by the negative Ca2
control loop (cf. Figures 1A and 1B). Consistent with thisof the luciferase light signal over growth inhibition, indi-
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regulatory model, compound 3 was found to inhibit the
reporter gene signal in all three strains, pIB102EL, pI-
B102AL, and pIB102FL, to more or less the same extent
(Figure 5B). These results suggest that compound 3
targets LcrF directly or, more likely, acts on regulatory
elements upstream of LcrF, thus explaining the block
of expression of YerA and YopE. Compounds 2 and 4,
on the other hand, were found to enhance the expression
from the lcrF promoter in pIB102FL at concentrations
that reduce expression of YopE (Figures 5A and 5C).
For compound 2, this increase in expression from the
lcrF promoter was dose independent in the concentra-
tion range investigated (Figure 5A). Compound 4, on the
other hand, produced a peak around 5M and a modest
inhibition above 10 M (Figure 5C). The selectivity pat-
terns observed for compound 2 and 4 suggest that these
compounds might target Yop secretion or the Ca2-
dependent regulation involving the negative LcrQ loop
rather than the temperature-dependent LcrF activating
cascade (cf. Figures 1A and 1B). Under the assay condi-
tions, LcrF is expressed at elevated levels, and currently
we cannot explain why LcrF expression is stimulated.
However, this observation is potentially important since
the mechanisms that regulate LcrF are poorly under-
stood.
Western analysis was performed in order to establish
inhibition of actual Yop secretion in the presence of
compounds 2–4. The wild-type strain pIB102EL was
grown at ambient temperature (21C) in the presence
or absence of different compound concentrations for 1
hr and then shifted to 37C to allow induction and secre-
tion of the Yops. After 2.5 hr at 37C, the bacteria were
removed by centrifugation, and the protein content in
Figure 6. Inhibition of Yop Secretion
the supernatant, i.e., the surrounding media, was exam-
Compounds 2–4 inhibit Yop secretion. Yop secretion from the wild-
ined by Western analysis using a polyclonal serum active type strain pIB102EL in presence of different concentrations of com-
against all secreted Yops. As seen in Figures 6A–6C, pounds 2–4 was investigated by Western analysis.
compounds 2–4 efficiently inhibited Yop secretion in a
dose-dependent manner, and the IC50 values for inhibi-
bacterial motility and Yop transcription in the presencetion of the luciferase readout (cf. Figures 4B–4D) match
of compounds 2–4 were investigated. The experimentsthe IC50 values for inhibition of Yop secretion (cf. Figures
were carried out in six-well plates with Ca2-depleted6A–6C). These experiments demonstrate that an ob-
migration agar containing different concentrations ofserved inhibition of actual Yop secretion corresponds
compounds 2–4. A small volume of a pIB102EL cultureto an inhibition of Yop expression.
was dispensed in the center of each well, and the platesInterestingly, several of the proteins that constitute
were incubated at 22C for 18 hr. During the incubation,the Ysc TTS system for Yop secretion have homologs in
motile bacteria will form a circular zone of bacteriathe secretion system used for assembly of the flagellum
spreading from the center of the well. The plates were[10]. Preferably, chemical probes for investigation of
then shifted to 37C for 3 hr to allow onset of Yop expres-the regulation and function of the Ysc TTS should be
sion and secretion. n-decanal was subsequently addedselective for the Yop secretion pathway, while candi-
to each well, and light emission resulting from Yop anddates for drug development might benefit from inhibiting
luciferase expression was recorded with the light-sensi-both processes. Y. psedotuberculosis flagella assembly
tive camera and subsequently quantified. The platesmutants have been found to be avirulent in a mouse
were photographed in visible light, and the diametersinfection model (H.W.-W. et al., unpublished results),
of the motility zones were measured. DMSO aloneand motility was found to be required to initiate invasion
proved to have little or no effect on motility but causedby Y. enterecolitica [29]. Recent studies with Y. entero-
up to 45% inhibition of the luxAB reporter gene signalcolitica show that the flagellar, Ysc, and the chromosom-
(Figures 7A–7F). A dose-dependent inhibition of bothally encoded Ysa TTS machineries all are capable of
motility (Figure 7A) and the reporter gene signal (Figuresecretion of extracellular proteins, and thus certain pro-
7B) was observed for compound 2. However, the experi-teins can be secreted by more than one system [13, 30].
ment does not address if compound 2 shows a quantifi-Thus, compounds that target multiple TTS systems can
able selectivity for any of the two TTS systems. Com-provide valuable insights in common themes in TTS
pound 3, on the other hand, had virtually no effect onwithin a certain bacterium. In order to study selectivity
for inhibition of Yop TTS over TTS flagellum assembly, motility (Figure 7C) at concentrations causing strong or
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Figure 7. Investigation of Selectivity for Inhibition of Yop Type III Secretion over Flagellar Type III Secretion and Motility
Investigation of flagellum mediated motility (in [A], [C], and [E], the black bars indicate diameter of the zones of motility) and luciferase light
emission as a result of transcription from the yopE promoter (B, D, and F) in the presence of increasing concentrations (wells 3–6) of compounds
2–4. In (A)–(F), well 1, no additives; well 2, DMSO control. In (A) and (B), wells 3–6, 5, 10, 20, and 50 M, respectively, of 2. In (C) and (D),
wells 3–6, 2, 5, 10, and 20 M, respectively, of 3. In (E) and (F), wells 3–6: 5, 10, 20, and 50 M, respectively, of 4.
complete inhibition of the reporter signal (Figure 7D). 2 is the most potent. Compounds belonging to this class
of hydrazones and their corresponding metal complexesThese results indicate that the TTS system responsible
for flagellum assembly is fully functional and that bacte- have been prepared and evaluated for biological activity
including antibacterial activity (see [31–33] for some ex-rial growth is unaffected. Motility was not affected by
compound 4 (Figure 7E) while a 45% dose-indepen- amples), and cytotoxicity against tumor cell lines has
been reported ([34] and references therein). Compounddent inhibition of the reporter gene signal was observed
(Figure 7F). This dose independence might be explained 3, clioxanide, is a known antihelmintic O-acetyl salicyl-
anilide [35], and antimicrobial effects have been re-by the fact that a precipitate formed in the wells con-
taining higher concentrations of compound 4 (Figure 7E, ported for various salicylanilides [36]. Compounds simi-
lar to 3 but lacking the acetyl group are weakly acidicwells 5 and 6). Yop secretion is effectively inhibited by
compound 4 (Figure 6C), but the effect on motility at compounds known to induce uncoupling of oxidative
phosphorylation, resulting in inhibition of ATP synthesishigher concentrations is unclear due to the limited solu-
bility. Compound 3, on the other hand, is highly selective [37]. Recent studies also describe that salicylanilides
closely related to 3 inhibit bacterial two-component sys-and targets the regulation and secretion of Yops without
effect on flagellum assembly and motility. Our results tems [38, 39], and it is possible that compound 3 acts
on a Yersinia two-component system that affects theobtained with different reporter gene strains (Figure 5B)
suggest that compound 3 acts on a target upstream of Ysc TTS. This is a potentially interesting observation
since no role of a two-component system has beenthe temperature-triggered activator LcrF. The Ysa and
flagellar TTS system are active at low temperature, and implicated in regulation and secretion of Yops. Com-
pound 4 and related derivatives have been found tothe lack of inhibition of motility further supports that
compound 3 targets regulation of the Ysc TTS system display in vivo antihelmintic activity [40] and show low
or no toxic effect in vivo [41].in a highly selective mode. Compound 2, on the other
hand, inhibits both processes, possibly by inhibition of In conclusion, we have employed a robust reporter
gene assay in viable bacteria to identify inhibitors of Yscclosely related proteins involved in secretion of Yops
and construction of the flagellum. type III secretion in Yersinia. Several compounds were
identified that inhibit secretion in a direct or indirectThe bacterial targets in Y. pseudotuberculosis for
compounds 1-4 are unknown at this stage. The com- manner at concentrations at which no or weak inhibition
of bacterial growth was observed. Moreover, the selec-pounds are synthetic derivatives that can be prepared
in five or less chemical steps utilizing commercially avail- tivity patterns observed for these compounds indicate
that they inhibit different pathways regulating Yop ex-able starting materials. These short synthetic sequences
are well suited for synthesis of second-generation librar- pression and secretion. The compounds have a selec-
tive mode of action and have different effects on theies, e.g., by parallel solution synthesis and establish-
ment of structure-activity relationships. Several of the flagellum assembly and motility. We now plan to employ
these compounds in in vitro and in vivo experiments tohits from the primary screening belong to a class of
acylated salicylaldehyde hydrazones, of which compound further study TTS in Yersinia and other gram-negative
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construct, the negative self-regulatory C-terminal helix-loop-helixbacteria. This set of chemical probes will hopefully aid
region has been deleted. The resulting strains, pIB29EL (yopE-the elucidation of the molecular events leading to Yop
luxAB), pIB29AL (yerA-luxAB), pIB102EL [25] (yopE-luxAB, wild-translocation and inhibition of the innate immune re-
type), pIB102AL (yerA-luxAB, wild-type), and pIB102FL (lcrF-luxAB,
sponse. Importantly, these inhibitors also constitute ex- wild-type), were grown at room temperature on LB plates containing
amples of antibacterial agents with a novel mode of chloramphenicol (Sigma) at a final concentration of 50 g/ml. From
plates not older than 1 week, bacteria for experiments were grownaction, i.e., inhibition of virulence. The bacterial targets
in liquid brain/heart infusion (BHI) broth (Oxoid; Unipath Ltd., Ba-of these inhibitors are unknown, and our efforts will
sington, UK) containing 2.5 mM CaCl2 or 20 mM MgCl2 and 5 mMfocus on target identification and optimization with the
EGTA for Ca2 depletion and 19 g/ml chloramphenicol.goal to increase selectivity and potency. Identification
of this set of inhibitors illustrates the approach of utiliz- Compounds, Antibiotics, and Antibodies
ing cell-based assays to identify compounds that affect The chemical library that consists of 9,400 unique compounds in
complex virulence systems in a direct or indirect 96-well plate format was purchased from ChemBridge (Diverset F).
The compounds were dissolved in DMSO to give a stock solutionmanner.
of 2 mg/ml. For compounds further characterized in the described
experiments, additional 5 or 10 mg samples were purchased fromSignificance
ChemBridge. Streptomycin (Sigma), carbenicillin (Sigma), polymyxin
B (mixture of polymyxin B1 and B2, Fluka), and nalidixic acid (Sigma)
As a result of changes in human lifestyle and the re- were dissolved in water. Antibodies against the different Yersinia
proteins were available from other projects at the department ofmarkable capacity of bacteria to develop resistance,
Molecular Biology, Umea˚ University.bacterial infections are again considered to be a major
threat to human health. One strategy to overcome bac-
General Screening and Assay Conditionsterial resistance is to develop antibacterial agents that
An overnight culture grown at room temperature in BHI medium
target virulence mechanisms, i.e., events that enable containing 20 mM MgCl2 and 5 mM EGTA for Ca2 depletion was
the bacterium to enter the host, disarm the host’s diluted to OD600  0.15–0.25 (10 mm path length). In parallel, the
defense, multiply, and finally spread within the host or compounds to be tested were dispensed into the wells of a white
96-well plate (FluoroNunc, Nunc) containing 50 l of medium perto a new host. Various pathogenic bacteria use related
well. To each well, 50 l of the bacterial solution was added. Forvirulence systems, of which the Ysc type III secretion
compounds dissolved in DMSO, the final DMSO concentration was(TTS) system of Yersinia represents one of the arche-
kept below 2%. The plate was incubated on an orbital shaker at
types. During infection, Yersinia bacteria adhere to room temperature (21C) for 1 hr. The temperature was then shifted
immune cells, e.g., macrophages, and use the TTS to 37C, and incubation with shaking was continued for 2 hr. Subse-
machinery to make a pore in the membrane of the quently, the temperature was shifted back to room temperature,
and the plate was incubated for 2 hr without shaking. Finally, 100target cell and subsequently inject a set of effector
l freshly made n-decanal emulsion (Sigma; 10 l/100 ml water,proteins that inhibit the innate immune response. In
emulsified by vigorous shaking) was added to each well, and thethe present study, a luciferase reporter gene system
light emission was measured within 1–3 min after addition. Light
in Yersinia pseudotuberculosis was used to screen a emission was recorded with a light-sensitive charge-coupled device
chemical library consisting of 9,400 compounds in (CCD) camera, DIANA chemoilluminescence detection module
order to identify molecules that target known or un- (Raytest, Isotopenmegera¨te, GmbH). The intensity of the light sig-
nals was quantified using the computer program TINA (version 2.0).known components directly or indirectly involved in
Primary screening of the compound library was carried out in dupli-TTS. The screening process furnished compounds
cate with a final concentration of 20 g/ml. Other experiments werethat inhibit the reporter gene signal expressed from
carried out in quadruplicate with modifications as indicated in the
the yopE promoter and effector protein secretion in a text and figure legends. For antibody experiments, 5 l monoclonal
dose-dependent manner (IC50  50 M) at concentra- mouse ascites solution was used per well. Results were typically
tions with no or modest effect on bacterial growth. reproduced in at least three independent experiments.
Three of the inhibitors were investigated in detail, and
Growth Inhibition Experimentsthe selectivity patterns observed for inhibition of vari-
Growth inhibition was measured by growing bacteria at 37C in theous reporter gene strains indicate that the compounds
presence of different compound concentrations in 96-well platestarget the TTS machinery at different levels. Since
containing 100 l bacterial culture in BHI medium with 2.5 mM CaCl2these compounds inhibit TTS without detrimental ef- per well. The experiments were carried out in a Molecular Device
fect on growth, they are valuable chemical tools for Spectramax 340 plate reader with continuous shaking at 37C and
periodic determination of absorption at the wavelength 600 nm.investigation of TTS-dependent virulence. Further-
Experiments were carried out in triplicate or quadruplicate, andmore, these inhibitors may apply less pressure for de-
the results were typically reproduced in at least three independentvelopment of resistance than conventional antibiotics.
experiments. Growth inhibition was quantified based on growthImportantly, several components of different TTS sys-
rates observed in the presence and absence of compound over a
tems are interchangeable, and data generated with period of time (typically 3–4 hr) with approximately linear growth.
Yersinia are likely to be valid also for other gram-
negative bacteria. Western Analysis of Protein Secretion
An overnight culture grown at room temperature in BHI medium
containing 20 mM MgCl2 and 5 mM EGTA for Ca2 depletion wasExperimental Procedures
diluted to OD600  0.15–0.25. In parallel, the compounds to be tested
were dispensed into the wells of a 96-well plate containing 50 l ofBacterial Strains and Growth Conditions
Y. pseudotuberculosis serotype III strains with the luxAB contruct medium per well. To each well, 50 l of the bacterial solution was
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berculosis pIB29 [27] or the wild-type Y. pseudotuberculosis pIB102 perature for 1h. The temperature was then shifted to 37C, and
incubation with orbital shaking was continued for 2.5 hr. Subse-[26] by constructing yopE-luxAB, yerA-luxAB, and lcrF-luxAB op-
eron fusions essentially as described previously [25]. In the lcrF quently, the cultures were transferred to microcentrifuge tubes. After
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